• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

铂化合物在人体肿瘤中的摄取。体外研究。

Uptake of platinum compounds in human tumors. In vitro study.

作者信息

Hecquet B, Leroy A, Lefebvre J L, Peyrat J P, Adenis L

出版信息

Bull Cancer. 1986;73(5):535-41.

PMID:3535936
Abstract

The kinetics of intratumoral uptake of cisplatin, carboplatin (CBDCA) and TNO-6 were studied in vitro in fragments of tumors of the head and neck maintained in culture medium under conditions simulating therapeutic conditions of chemo-embolization. Cisplatin and TNO-6 are more rapidly taken up than CBDCA (carboplatin). With each of these compounds, after 24 hours a fraction of the platinum taken up is not irreversibly bound to the tissue. The rate of uptake and the proportion of platinum irreversibly bound depends a great deal on the tumor under study. The characteristics of the diffusion indicate that TNO-6 is better used with chemo-embolization than with systemic injection. The opposite finding is seen with carboplatin. Cisplatin appears to to be about equally well-suited for either method of injection.

摘要

在模拟化疗栓塞治疗条件下,将头颈部肿瘤碎片置于培养基中进行体外培养,研究了顺铂、卡铂(CBDCA)和TNO-6在肿瘤内的摄取动力学。顺铂和TNO-6比卡铂(CBDCA)摄取更快。使用这些化合物中的每一种,24小时后摄取的一部分铂并未不可逆地与组织结合。摄取速率和铂不可逆结合的比例在很大程度上取决于所研究的肿瘤。扩散特征表明,TNO-6与化疗栓塞联合使用比全身注射效果更好。卡铂则相反。顺铂似乎同样适合这两种注射方法。

相似文献

1
Uptake of platinum compounds in human tumors. In vitro study.铂化合物在人体肿瘤中的摄取。体外研究。
Bull Cancer. 1986;73(5):535-41.
2
Mechanism of cytotoxicity of anticancer platinum drugs: evidence that cis-diamminedichloroplatinum(II) and cis-diammine-(1,1-cyclobutanedicarboxylato)platinum(II) differ only in the kinetics of their interaction with DNA.抗癌铂类药物的细胞毒性机制:顺二氯二氨铂(II)和顺二氨(1,1-环丁烷二羧酸根)铂(II)仅在与DNA相互作用的动力学方面存在差异的证据。
Cancer Res. 1986 Apr;46(4 Pt 2):1972-9.
3
Comparison of platinum concentrations in human head and neck tumours following administration of carboplatin, iproplatin or cisplatin.卡铂、异丙铂或顺铂给药后人体头颈部肿瘤中铂浓度的比较。
Bull Cancer. 1987;74(4):433-6.
4
cis-Amminedichloro(2-methylpyridine) platinum(II) (AMD473), a novel sterically hindered platinum complex: in vivo activity, toxicology, and pharmacokinetics in mice.顺式二氯(2-甲基吡啶)氨铂(II)(AMD473),一种新型空间位阻铂配合物:小鼠体内活性、毒理学及药代动力学
Clin Cancer Res. 1997 Nov;3(11):2063-74.
5
Platinum agents in the treatment of osteosarcoma: efficacy of cisplatin vs. carboplatin in human osteosarcoma cell lines.铂类药物治疗骨肉瘤:顺铂与卡铂对人骨肉瘤细胞系的疗效比较
Med Pediatr Oncol. 2002 Dec;39(6):573-80. doi: 10.1002/mpo.10076.
6
Inductively coupled plasma mass spectroscopy quantitation of platinum-DNA adducts in peripheral blood leukocytes of patients receiving cisplatin- or carboplatin-based chemotherapy.电感耦合等离子体质谱法定量分析接受顺铂或卡铂化疗患者外周血白细胞中的铂-DNA加合物。
Clin Cancer Res. 1996 Nov;2(11):1829-35.
7
In vitro phase II comparison of the cytotoxicity of a novel platinum analog, nedaplatin (254-S), with that of cisplatin and carboplatin against fresh, human cervical cancers.新型铂类类似物奈达铂(254-S)与顺铂和卡铂对新鲜人宫颈癌细胞毒性的体外II期比较
Gynecol Oncol. 1998 Nov;71(2):308-12. doi: 10.1006/gyno.1998.5140.
8
Preclinical antitumor evaluation of bis-acetato-ammine-dichloro-cyclohexylamine platinum(IV): an orally active platinum drug.双乙酸根-氨-二氯-环己胺铂(IV)的临床前抗肿瘤评估:一种口服活性铂类药物
Cancer Res. 1993 Jun 1;53(11):2581-6.
9
In vitro antitumor activity of a new platinum complex, cis-malonato [(4R,5R)-4,5-bis(aminomethyl)-2-isopropyl-1,3-dioxolane] platinum (II) (SKI 2053R), against human lung and stomach cancer cell lines.新型铂配合物顺式丙二酸根[(4R,5R)-4,5-双(氨甲基)-2-异丙基-1,3-二氧戊环]铂(II)(SKI 2053R)对人肺癌和胃癌细胞系的体外抗肿瘤活性
Anticancer Res. 1995 Jan-Feb;15(1):51-4.
10
Therapeutic effects of a new photosensitizer for photodynamic therapy of early head and neck cancer in relation to tissue concentration.一种用于早期头颈癌光动力治疗的新型光敏剂的治疗效果与组织浓度的关系
Auris Nasus Larynx. 2008 Dec;35(4):545-51. doi: 10.1016/j.anl.2007.10.008. Epub 2008 Feb 1.

引用本文的文献

1
A mathematical model for cisplatin cellular pharmacodynamics.顺铂细胞药效学的数学模型。
Neoplasia. 2003 Mar-Apr;5(2):161-9. doi: 10.1016/s1476-5586(03)80008-8.
2
Measurement of extracellular fluid carboplatin kinetics in melanoma metastases with microdialysis.用微透析法测量黑色素瘤转移灶中细胞外液卡铂的动力学。
Br J Cancer. 1996 Apr;73(7):920-4. doi: 10.1038/bjc.1996.164.
3
The combined effects of high-energy shock waves and cytostatic drugs or cytokines on human bladder cancer cells.高能冲击波与细胞毒性药物或细胞因子对人膀胱癌细胞的联合作用。
Br J Cancer. 1994 Jan;69(1):58-65. doi: 10.1038/bjc.1994.9.
4
Short-term cis-diamminedichloroplatinum(II) accumulation in sensitive and resistant human ovarian carcinoma cells.
Cancer Chemother Pharmacol. 1990;25(4):236-40. doi: 10.1007/BF00684878.
5
Clinical pharmacokinetics of carboplatin.卡铂的临床药代动力学
Clin Pharmacokinet. 1991 Oct;21(4):242-61. doi: 10.2165/00003088-199121040-00002.
6
Reduced drug accumulation as a major mechanism of acquired resistance to cisplatin in a human ovarian carcinoma cell line: circumvention studies using novel platinum (II) and (IV) ammine/amine complexes.药物蓄积减少作为人卵巢癌细胞系对顺铂获得性耐药的主要机制:使用新型铂(II)和(IV)氨/胺配合物的规避研究
Br J Cancer. 1992 Dec;66(6):1109-15. doi: 10.1038/bjc.1992.419.